IND SWIFT LABORATORIES LT Financial Ratios
INDSWFTLAB · Healthcare · Current price ₹357
P/E ratio
74.8x
P/B ratio
2.4x
ROE
0.0%
ROCE
3.6%
Debt / Equity
0.01
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 74.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.4x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 0.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 3.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.01 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with IND SWIFT LABORATORIES LT's latest numbers.
IND SWIFT LABORATORIES LT profitability
IND SWIFT LABORATORIES LT generates a return on equity of 0.0% and a return on capital employed of 3.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.01 and a P/E of 74.8x, IND SWIFT LABORATORIES LT is conservatively financed. Our overall business-quality score for the company is 2.6 / 10.
Understand the ratios
More on IND SWIFT LABORATORIES LT
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.